TSX open
Loading markets…

Advertisement

Stocks

Why Microbix Biosystems Inc. stock is skyrocketing today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:MBX.TO

Follow MBX

Photos provided by Pexels

Microbix Biosystems Inc. shares surged by over 5% in the latest trading session, showcasing a positive shift in market sentiment.

Microbix Biosystems Inc. (MBX.TO) experienced a notable increase of 5.26% in its stock price during the last trading day, closing at CA$0.30. This uptick suggests growing interest among investors, even without significant news announcements.

Advertisement

Microbix Biosystems Inc.

MBX.TO

Full stock page →

MBX.TO

Microbix Biosystems Inc.

Source:WealthAwesomeWealthAwesome
$0.07 (30.43%)
120 day period
$0.23$0.27$0.32Apr 2Jun 29Sep 23

Market cap

$41.78M

52W high

$0.33

52W low

$0.21

1W change

-3.23%

Beta

0.57

Analyst Price Targets

Based on analyst covering MBX · as of Sep 17, 2026

📉

Wall Street analysts forecast MBX stock price to fall 99.3% over the next 12 months.

Consensus

Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.40

-99.3% Upside

Current Price

C$57.89

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MBX's historical volatility

HistoricalForecast68%95%
C$0.15C$0.25C$0.34C$0.44C$0.54C$0.64TodayMay 15Jul 21Sep 23Nov 5Dec 19Jan 31

30-Day Vol

58.6%

Annualized

90-Day Vol

49.2%

Annualized

Trend (90d)

+7.1%

Annualized drift

90d Mean

C$0.31

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.30C$0.25C$0.37
60 trading daysC$0.31C$0.23C$0.41
90 trading daysC$0.31C$0.22C$0.44

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider Microbix's recent performance as a potential sign of increasing market confidence, despite the lack of major news.

Stock Price Climbs 5.26%

Microbix's market cap now stands at approximately CA$41.25 million, highlighting its relatively small size in the biotech sector.

Bull case

The recent rise in Microbix's stock price may reflect investor optimism about the company's future earnings potential. This is especially true following a recent quarterly revenue increase, which could be encouraging for shareholders.

Bear case

Despite the positive movement, investors should stay cautious. Microbix's profit margin remains negative, indicating ongoing financial challenges that could affect future performance.

Market Performance Overview

Advertisement

In the latest trading session, Microbix Biosystems Inc. saw its stock price rise by 5.26%, closing at CA$0.30. This increase comes amid growing investor interest, despite no major news from the company. The market cap now stands at approximately CA$41.25 million, positioning Microbix as a smaller player in the biotech sector.

Investor Sentiment

The uptick in Microbix's stock price may indicate a shift in investor sentiment, likely driven by positive expectations about the company's future. Reports of increased revenues, including a 13% rise in Q1 2026, could be fueling optimism among shareholders. However, it's important to keep in mind the company's negative profit margin, which highlights ongoing financial challenges.

Looking Ahead

As Microbix prepares to release its Q2 fiscal 2026 results on May 14, 2026, investors will be closely watching for any developments that could impact the stock's trajectory. The upcoming results may provide additional insights into the company's operational efficiency and market strategy.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 15, 2026
Last Updated: June 15, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement